Baby jumpsuit could spot developmental delays in remote areas
NCT ID NCT05782673
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a wearable jumpsuit called MAIJU that measures how babies move at home. Researchers will track about 100 infants in rural Malawi from 6 to 18 months old, comparing their motor development with later neurodevelopmental outcomes. The goal is to see if this simple device can reliably assess motor skills in low-income settings.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MAIJU jumpsuit (wearable device)
- What this could lead to
- If successful, this could provide a simple, home-based tool to track infant motor development in low-resource settings, helping identify delays early.
- What could go wrong
- This is an early feasibility study with only 100 infants, so results may not apply broadly. The device may not work well in all rural conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2023
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All infants born in the catchment area of Lungwena health center are screened, and the infants are contacted if they fullfil the eligibility criteria.
- Ages
-
4 to 24 months
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * A documented birth date * Birth at about term age, i.e. between 35 and 42 gestation weeks * Mother's ability to speak fluently Chi-Chewa, Chi-Yao or English * Permanent resident of Lungwena Health Centre catchment area * Availability and willingness of the mother and infant during the period of the study * Signed or thumb-printed informed consent by the caregiver of the infant Exclusion Criteria: * Very early birth (at 7th month or earlier) based on mother's information * Infant's congenital malformation or severe illness as judged clinically by a study nurse
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infant development are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BABA, Clinical Trial Unit, New Children's Hospital
Helsinki, Finland
-
Kamuzu University of Health Sciences
Blantyre, 3, Malawi
-
Lungwena Health Center
Mangochi, Mangochi district, Malawi
-
University of Helsinki
Helsinki, 00250, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Play-Based coaching program help preterm babies thrive at home?
- A Baby's fidgets may reveal brain health: study tests early warning signs
- Can a switch to goat milk formula prevent baby eczema?
- Can reading a Preemie's cues speed up independent feeding?
- A nationwide test: do home visits build healthier families?
- Could a gentler ICU environment boost brain development in heart babies?